Granted Patent
B2
US 8,841,331 · App. 13/683,706 · Granted Sep 23, 2014
Inhibitors of human immunodeficiency virus replication
Inventors:
Christiane Yoakim (Laval, CA); Murray D. Bailey (Laval, CA); Francois Bilodeau (Laval, CA); Rebekah Carson (Laval, CA); Lee Fader (Laval, CA); Stephen Kawai (Laval, CA); Sebastien Morin (Laval, CA); Carl Thibeault (Laval, CA); Bruno Simoneau (Laval, CA); Simon Surprenant (Laval, CA); Youla S. Tsantrizos (Laval, CA); Steven R. Laplante (Laval, CA)
Assignee:
Gilead Sciences, Inc.
C07D213/81A61K31/4741C07D401/12C07D405/14C07D417/10A61K31/506A61K31/501A61K31/44A61K31/4375A61K45/06C07D491/06C07D413/14C07D471/04C07D213/55C07D405/10A61K31/4436C07D498/06A61K31/444A61K31/5383C07D413/10C07D411/10A61K31/4709A61K31/538A61K31/4439A61K31/4433
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Compounds of formula I: wherein a, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are defined herein, are useful as inhibitors of HIV replication.
Claims (3)
1. A compound, or a pharmaceutically acceptable salt thereof, having the formula:
2. A pharmaceutical composition comprising the compound of claim 1 , or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable carriers.
3. A method of treating HIV infection comprising administering to a host infected by HIV a therapeutically effective amount of the compound of claim 1 , or a pharmaceutically acceptable salt thereof.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 1, 2013
From: KAWAI, STEPHEN; BILODEAU, FRANCOIS; YOAKIM, CHRISTIANE; BAILEY, MURRAY D.; CARSON, REBEKAH; FADER, LEE; MORIN, SEBASTIEN; THIBEAULT, CARL; SIMONEAU, BRUNO; SURPRENANT, SIMON; LAPLANTE, STEVEN R.; TSANTRIZOS, YOULA S.
To: GILEAD SCIENCES, INC.
Reel/Frame 030124/0757 →
Continuity (4)
Provisional Application
61178551
· May 15, 2009
Provisional Application
61285766
· Dec 11, 2009